TABLE 2

Analysis According to Top 5 APR-DRGs

CharacteristicSHARPGM ServiceP
141, asthman = 400n = 1113
 LOS, d2 (2–3)2 (2–3).003
 Total costs, US$2257 (1948–3508)2494 (2049–3648).002
138, bronchiolitis and RSV pneumonian = 269n = 747
 LOS, d2 (2 –3)3 (2–3).444
 Total costs, US$2390 (1712–3546)2753 (1768–4082).097
139, pneumonian = 217n = 554
 LOS, d3 (2–4)3 (2–4).196
 Total costs, US$3173 (2039–4638)3342 (2037–4890).252
113, infections of upper respiratory tractn = 169n = 536
 LOS, d2 (2–3)2 (2–3).964
 Total costs, US$2526 (1699–3641)2535 (1728–3787).561
249, nonbacterial gastroenteritisn = 116n = 347
 LOS, d2 (2–3)2 (2–3).059
 Total costs, US$2082 (1660–3236)2543 (1778–3613).032
  • Data are presented as median values (interquartile range).